John D. Crispino
Affiliations: | University of Chicago, Chicago, IL |
Area:
Molecular Biology, BiochemistryGoogle:
"John Crispino"Mean distance: (not calculated yet)
Children
Sign in to add traineeRahul S. Bhansali | grad student | (Cell Biology Tree) | |
Yanfei Xu | grad student | 2005 | Chicago |
Cindy G. Leung | grad student | 2006 | Chicago |
Andrew G. Muntean | grad student | 2006 | Chicago |
Gina T. Kirsammer | grad student | 2007 | Chicago |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jin Q, Gutierrez Diaz B, Pieters T, et al. (2022) Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia. Science Advances. 8: eabq8437 |
Zhao X, Bartholdy B, Yamamoto Y, et al. (2022) PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development. Communications Biology. 5: 961 |
Rammohan M, Harris E, Bhansali RS, et al. (2022) The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target. Oncogene |
Bhansali RS, Rammohan M, Lee P, et al. (2021) DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3. The Journal of Clinical Investigation. 131 |
Schieber M, Marinaccio C, Bolanos LC, et al. (2020) FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome. Blood Cancer Journal. 10: 98 |
Fang C, Rao S, Crispino JD, et al. (2020) Determinants and role of chromatin organization in acute leukemia. Leukemia |
Laurent AP, Siret A, Ignacimouttou C, et al. (2020) Constitutive activation of RAS/MAPK pathway cooperates with trisomy 21 and is therapeutically exploitable in Down syndrome B-cell leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Fruit C, Couly F, Bhansali R, et al. (2019) Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-]quinazolin-9(8)-one, a Promising Inhibitor of DYRK1A. Pharmaceuticals (Basel, Switzerland). 12 |
Strouboulis J, Crispino JD. (2019) Preface to IUBMB life special issue on GATA transcription factors in development, differentiation, and disease. Iubmb Life |
Ling T, Crispino JD. (2019) GATA1 mutations in red cell disorders. Iubmb Life |